본문으로 건너뛰기
← 뒤로

Micropapillary Urothelial Carcinoma: A Review and Update.

1/5 보강
Advances in anatomic pathology 📖 저널 OA 4.5% 2025: 0/3 OA 2026: 1/16 OA 2025~2026 2026 Vol.33(2) p. e1-e8
Retraction 확인
출처

Basar M, Yol C, Chen JF, Al-Ahmadie H

📝 환자 설명용 한 줄

Micropapillary urothelial carcinoma is a well-recognized subtype of urothelial carcinoma that is associated with an aggressive clinical course.

이 논문을 인용하기

↓ .bib ↓ .ris
APA Basar M, Yol C, et al. (2026). Micropapillary Urothelial Carcinoma: A Review and Update.. Advances in anatomic pathology, 33(2), e1-e8. https://doi.org/10.1097/PAP.0000000000000527
MLA Basar M, et al.. "Micropapillary Urothelial Carcinoma: A Review and Update.." Advances in anatomic pathology, vol. 33, no. 2, 2026, pp. e1-e8.
PMID 41609241 ↗

Abstract

Micropapillary urothelial carcinoma is a well-recognized subtype of urothelial carcinoma that is associated with an aggressive clinical course. Its recognition is critical for optimal management; however, strict diagnostic criteria are not always applied, resulting in interobserver variability in recognition and reporting. The genomic profiles of micropapillary urothelial carcinoma overlap with those of classic urothelial carcinoma, but show higher rates of alterations in the cell cycle regulators TP53 and RB1 and the receptor tyrosine kinase ERBB2 . Recently approved therapeutic agents targeting cell surface markers such as HER2 and NECTIN4 provide promising novel and potentially more effective therapies for micropapillary urothelial carcinoma.

🏷️ 키워드 / MeSH 📖 같은 키워드 OA만

🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반